These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 37545736)

  • 21. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.
    Claassen DO; Josephs KA; Ahlskog JE; Silber MH; Tippmann-Peikert M; Boeve BF
    Neurology; 2010 Aug; 75(6):494-9. PubMed ID: 20668263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies.
    Turner RS
    J Geriatr Psychiatry Neurol; 2002; 15(4):195-9. PubMed ID: 12489915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluid markers of synapse degeneration in synucleinopathies.
    Cervantes González A; Belbin O
    J Neural Transm (Vienna); 2022 Feb; 129(2):187-206. PubMed ID: 35147800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.
    Habibi M; Oertel WH; White BJ; Brien DC; Coe BC; Riek HC; Perkins J; Yep R; Itti L; Timmermann L; Best C; Sittig E; Janzen A; Munoz DP
    J Neurol; 2022 Sep; 269(9):4920-4938. PubMed ID: 35501501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: An Update.
    Zhang F; Niu L; Liu X; Liu Y; Li S; Yu H; Le W
    Aging Dis; 2020 Apr; 11(2):315-326. PubMed ID: 32257544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.
    Palermo G; Del Prete E; Bonuccelli U; Ceravolo R
    J Neurol; 2020 Dec; 267(12):3444-3456. PubMed ID: 32594302
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Granek Z; Barczuk J; Siwecka N; Rozpędek-Kamińska W; Kucharska E; Majsterek I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of autophagic protein DEF8 in Lewy bodies.
    Tanaka MT; Miki Y; Bettencourt C; Ozaki T; Tanji K; Mori F; Kakita A; Wakabayashi K
    Biochem Biophys Res Commun; 2022 Oct; 623():170-175. PubMed ID: 35921708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sleep behavior disorder (RBD) in synucleionopaties].
    Glas Srp Akad Nauka Med; 2009; (50):7-15. PubMed ID: 20666111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical review of the prion hypothesis of human synucleinopathies.
    Tamgüney G; Korczyn AD
    Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
    Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.
    Boeve BF; Silber MH; Ferman TJ; Lin SC; Benarroch EE; Schmeichel AM; Ahlskog JE; Caselli RJ; Jacobson S; Sabbagh M; Adler C; Woodruff B; Beach TG; Iranzo A; Gelpi E; Santamaria J; Tolosa E; Singer C; Mash DC; Luca C; Arnulf I; Duyckaerts C; Schenck CH; Mahowald MW; Dauvilliers Y; Graff-Radford NR; Wszolek ZK; Parisi JE; Dugger B; Murray ME; Dickson DW
    Sleep Med; 2013 Aug; 14(8):754-62. PubMed ID: 23474058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - A systematic review on potential biomarkers for neurodegeneration.
    Heller J; Brcina N; Dogan I; Holtbernd F; Romanzetti S; Schulz JB; Schiefer J; Reetz K
    Sleep Med Rev; 2017 Aug; 34():23-33. PubMed ID: 27542516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomic Dysfunction in α-Synucleinopathies.
    Mendoza-Velásquez JJ; Flores-Vázquez JF; Barrón-Velázquez E; Sosa-Ortiz AL; Illigens BW; Siepmann T
    Front Neurol; 2019; 10():363. PubMed ID: 31031694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic biomarkers in prodromal α-synucleinopathies: DAT binding and REM sleep without atonia.
    Kunz D; Stotz S; de Zeeuw J; Papakonstantinou A; Dümchen S; Haberecht M; Plotkin M; Bes F
    J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):532-540. PubMed ID: 36725328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.
    Singer W; Schmeichel AM; Shahnawaz M; Schmelzer JD; Boeve BF; Sletten DM; Gehrking TL; Gehrking JA; Olson AD; Savica R; Suarez MD; Soto C; Low PA
    Ann Neurol; 2020 Sep; 88(3):503-512. PubMed ID: 32557811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep and circadian rhythms in α-synucleinopathies-Perspectives for disease modification.
    Kunz D; Oster H; Rawashdeh O; Neumann WJ; Münte T; Berg D
    Acta Physiol (Oxf); 2023 May; 238(1):e13966. PubMed ID: 36951649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.